Abstract:Objective:To analyze the clinical features of type 2 diabetic patients with insulin autoimmune syndrome after treatment with exogenous insulin.Methods:A total of 106 patients with type 2 diabetes diagnosed with exogenous insulin-related insulin autoimmune syndrome (EIAS) were included from September 2017 to March 2019 in the Department of Endocrinology, Zhongshan Hospital, Fudan University. The clinical data, physical examination, and laboratory examination results of patients were collected.Results:Of the 106 patients, 84 (79.24%) used premixed human insulin or premixed insulin analogs, and 18 patients (16.98%) presented recurrent hypoglycemia. The arginine stimulation test showed that the median value of the baseline insulin was 73.40 (23.07-146.75) μU/ml, and the median ratio of 4 minute insulin to 0 minute insulin was 1.27 (1.03-1.85), with the mean of the ratio 1.72±1.47. The ratio of baseline insulin (μU/ml) to C-peptide (ng/ml) was 44.60 (14.92-87.93), with an average of 81.92±130.93. Taking the two-fold upper limit of fasting insulin reference value (49.8 μU/ml) as the cut-off point, the subjects were divided into insulin accumulation group (baseline insulin≥49.8 μU/ml) and insulin non-accumulation group (baseline insulin <49.8 μU/ml). Among the 66 patients in the insulin accumulation group, 14 patients had hypoglycemia (21.21%) and 4 patients in the insulin non-accumulation group presented hypoglycemia (10%). The ratio of 4 minute insulin to baseline insulin, ratio of baseline insulin to C-peptide, blood glucose level standard deviation (SDBG) and maximum blood glucose fluctuation amplitude (LAGE) in the insulin accumulation group were significantly higher than those in the insulin non-accumulation group (all P<0.05). Among 66 patients in the insulin accumulation group, 36 patients changed the type of insulin preparafion (insulin treatment group), 30 patients were changed from insulin to oral hypoglycemic agents (oral medication group). After treatment, both SDBG and LAGE in the two groups were significantly lower than before treatment ( P<0.05). Conclusions:With the aggravation of exogenous insulin accumulation, the fluctuation of blood glucose and the proportion of hypoglycemia were significantly increased. There was a characteristic change in islet function in patients with insulin autoimmune syndrome. After arginine stimulation, there was no significant peak of insulin secretion, showing a " high-level" curve. The baseline insulin/C-peptide ratio was significantly increased. The prognosis of EIAS patients is good after timely diagnosis and adjustment of treatment.

Allergic reaction to insulin analogue：14 cases report and literature review

Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report

A case report of pharmaceutical care for insulin allergy patient

Diagnosis and treatment of insulinoma:analysis of 17 cases

Long-acting insulin allergy in a diabetic child

The complexities of insulin allergy: a case and approach

Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review

A case of insulin allergy successfully managed using multihexamer-forming insulin degludec combined with liraglutide

Can a faulty injection technique lead to a localized insulin allergy?

Analysis of adverse drug reaction of antidiabetic agents according to documents within forty-two years in China

Analysis on clinical features of 106 type 2 diabetic patients complicated with insulin autoimmune syndrome

Faulty Injection Technique: A Preventable But Often Overlooked Factor in Insulin Allergy

Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database

Analysis on Relationship Between Specific IgG Antibodies of 14 Food Allergens and Allergic Skin Diseases

1093-P: the Prevalence and Clinical Characteristics of Insulin Antibody Formation in Patients with Type 2 Diabetes Treated with Insulin

Analysis on Adverse Drug Reaction Reports of Shanghai Oral Anti-Diabetic Drugs from 2006 to 2010

The relationship between first-phase insulin secretion and the therapeutic regimen in type 2 diabetes mellitus

A novel treatment of hyperinsulinemic hypoglycemia induced by insulin antibodies with alkali administration: a case report

Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years

Exogenous insulin autoimmune syndrome: A case report and review of literature

Clinical Features and Treatment of Pediatric Patients with Drug-Induced Anaphylaxis: a Study Based on Pharmacovigilance Data